Cargando…
Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009–2012
OBJECTIVES: Assess the disease severity of Shiga toxin-producing Escherichia coli (STEC) O157 infection and factors influencing the development of typical haemolytic uraemic syndrome (tHUS). DESIGN: A retrospective cohort study using data collected through routine surveillance questionnaires between...
Autores principales: | Launders, N, Byrne, L, Jenkins, C, Harker, K, Charlett, A, Adak, G K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735319/ https://www.ncbi.nlm.nih.gov/pubmed/26826153 http://dx.doi.org/10.1136/bmjopen-2015-009933 |
Ejemplares similares
-
Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome
por: Walsh, Patrick R., et al.
Publicado: (2018) -
Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study
por: Adams, Natalie, et al.
Publicado: (2019) -
Rare genetic variants in Shiga toxin-associated haemolytic uraemic syndrome: genetic analysis prior to transplantation is essential
por: Dowen, Frances, et al.
Publicado: (2017) -
Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case–control study
por: Doulgere, Julia, et al.
Publicado: (2015) -
Shiga Toxin–Producing Escherichia coli O157, England and Wales, 1983–2012
por: Adams, Natalie L., et al.
Publicado: (2016)